Feed ODI.ST
OD
ODI Pharma AB
ODI.ST · STO
2.46 kr +5.13% (+0.12 kr)
1M -7.87%
Market Cap 44.4M kr
P/E Ratio -
Div. Yield -
ROE 769.00%
Piotroski F-Score Weak
2/9Valuation
18 /100
Expensive P/S 4.98x
P/B 151.64x
P/E N/A
Growth
78 /100
Growing Rev. growth 115.01%
Book val. growth 55.54%
EPS growth N/A
Profitability
8 /100
Weak Gross margin 24.59%
Net margin 51.69%
Op. margin 44.28%
Quality
15 /100
Poor ROIC 1,349.66%
ROE 769.00%
ROA 62.31%
Debt
55 /100
Moderate Debt/Equity 0.00x
Current ratio 1.04x
Int. coverage -5.29x
Stability
26 /100
Unstable Beta 0.79x
Rev. volatility 9,209.38%
EPS volatility 467.33%
Întreabă StockBot despre ODI.ST
Online
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
CEO
Jan-Mark Edewaard
Employees
1
Headquarters
Stockholm